ELISSA CHUNG: Open Payments
NPI 1104338730 · WOODBURY, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 9 payments from 8 companies in 2025. Trend: 2023 $149 · 2024 $222 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Incyte Corporation | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| UCB, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: DUPIXENT, Sotyktu, OPZELURA, Bimzelx, EBGLYSS, SKYRIZI, OTEZLA.
Industry payments across MN — which companies pay providers there.
